I think they were asking is that your research in terms of fundamental analysis. The "research" you've just provided as an example is just TA/charting.
You can't compare to LDX as you have consistently been doing. The fundamentals of where they were at post non-approval is completely different to BOT's fundamentals post non-approval.
Ann: Botanix Partners with Telehealth Provider UpScriptHealth, page-23
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $674.2M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $2.266M | 6.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 558958 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 276289 | 7 |
View Market Depth
| Last trade - 14.47pm 16/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |